CILOXAN

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

CIPROFLOXACIN AS HYDROCHLORIDE

متاح من:

NOVARTIS ISRAEL LTD

ATC رمز:

S01AX13

الشكل الصيدلاني:

SOLUTION

تركيب:

CIPROFLOXACIN AS HYDROCHLORIDE 3 MG/ML

طريقة التعاطي:

OCULAR, OTIC

نوع الوصفة الطبية :

Required

المصنعة من قبل:

ALCON COUVREUR N.V., BELGIUM

المجموعة العلاجية:

CIPROFLOXACIN

المجال العلاجي:

CIPROFLOXACIN

الخصائص العلاجية:

Corneal ulcers and conjunctivitis caused by susceptible gram positive and gram negative microorganisms for adults and pediatric patients above the age of 1 year. For localized or diffuse otitis externa accompanied by a strong inflammatory reaction and of which the strains are susceptible to ciprofloxacin, and for the acute flare-up of a chronic otitis media. In this case, a mucopurulent secretion comes through the perforated eardrum. Pseudomonas aeruginosa is one of the organisms most likely to be found in this case. Also in other infections of the ear in which Pseudomonas aeruginosa and/or other susceptible strains may be demonstrated or suspected (for example with suppurating tympanic tubes), Ciloxan can be used under the strict supervision of an ear specialist. It must be understood that this is not a routine treatment and that improper use must be avoided.

تاريخ الترخيص:

2023-08-31

نشرة المعلومات

SH CIL APL AUG13 CL V1 COR MAT CL
PATIENT PACKAGE INSERT IN
ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) - 1986
The medicine is dispensed with
a doctor’s prescription only
CILOXAN
OCULAR AND OTIC SOLUTION
Active ingredient: Ciprofloxacin Base (as HCl) 3 mg/ml
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING
THE MEDICINE. This leaflet contains concise information
about the medicine. If you have further questions, refer to
the doctor or pharmacist. This medicine has been prescribed
for the treatment of your ailment. Do not pass it on to others.
It may harm them even if it seems to you that their medical
condition is similar.
1. WHAT IS THE MEDICINE INTENDED FOR?
THERAPEUTIC ACTIVITY:
Antibiotic eye and ear drops for the treatment of
inflammations caused by bacteria sensitive to ciprofloxacin
in adults and children over one year of age.
THERAPEUTIC GROUP:
Antibacterial antibiotics of the fluoroquinolone family.
2. BEFORE USING THE MEDICINE
X DO NOT USE THE MEDICINE IF:
∙ you have a known sensitivity to any of the ingredients
of the medicine or to other antibiotics of the quinolone
group.
SPECIAL WARNINGS REGARDING USE OF THIS MEDICINE:
! DO NOT USE THE MEDICINE WITHOUT CONSULTING THE
DOCTOR BEFORE STARTING TREATMENT:
∙ If you are pregnant or breastfeeding.
∙ Prolonged treatment may cause development of
resistant strains, including fungal infection.
∙ If you are sensitive to any type of food or medicine,
inform the doctor before taking the medicine.
∙ Stop treatment and immediately contact your doctor
if one or more of the following side effects occur: first
signs of a skin rash or any other allergic reaction,
including urticaria, itching, breathing problems. In case
of a severe allergic reaction - you may need emergency
medical care.
∙ If you experience pain, swelling or you developed an
inflammation while taking CILOXAN, or shortly after
taking it – Stop treatment and contact your doctor.
∙ Elderly people treated with steroids are at higher risk
of developing tendon proble

خصائص المنتج

CIL API OCT21 V3 Belgium update Oct 2020
1/11
1.
NAME OF THE MEDICINAL PRODUCT
CILOXAN
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml of solution contains 3 mg of ciprofloxacin (as hydrochloride).
Excipient with known effect: this medicine contains 0.06 mg of
benzalkonium chloride in each ml.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Eye and ear drops, solution.
A clear solution provided in a plastic bottle.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Corneal ulcers and conjunctivitis caused by susceptible gram positive
and gram negative microorganisms
for adults and pediatric patients above the age of 1 year.
For localized or diffuse otitis externa accompanied by a strong
inflammatory reaction and of which the
strains are susceptible to ciprofloxacin, and for the acute flare-up
of a chronic otitis media
.
In this case, a mucopurulent secretion comes through the perforated
eardrum. Pseudomonas aeruginosa
is one of the organisms most likely to be found in this case
.
Also in other infections of the ear in which Pseudomonas aeruginosa
and/or other susceptible strains
may be demonstrated or suspected (for example with suppurating
tympanic tubes), Ciloxan can be used
under the strict supervision of an ear specialist. It must be
understood that this is not a routine treatment
and that improper use must be avoided.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
OCULAR USE:
Adults and children 1 year and above.
Posology
Corneal ulcers
CILOXAN should be administered at the following intervals, even at
night:
•
Day 1: instil 2 drops into the affected eye every 15 minutes for the
first 6 hours and then 2 drops
every 30 minutes for the remainder of the day.
•
Day 2: instil 2 drops into the affected eye every hour.
•
Days 3 to 14: instil 2 drops into the affected eye every 4 hours.
CIL API OCT21 V3 Belgium update Oct 2020
2/11
•
If the treatment lasts longer than 14 days, the amounts can be
adjusted at the discretion of the
treating physician.
Superficial bacterial infections of th